Trizapime 80 Capsule contains Trimetazidine 80 mg, a metabolic agent used in the management of angina pectoris and ischemic heart disease. It works by improving myocardial glucose utilization, enhancing energy production in heart cells, and reducing the frequency and severity of angina attacks.
Belonging to the cardiology and anti-anginal segment, Trimetazidine is prescribed by cardiologists for patients experiencing chronic stable angina, particularly when conventional anti-anginal therapies are insufficient or poorly tolerated.
The capsule is valued for its cardioprotective properties, including the improvement of oxygen efficiency in heart muscle without altering heart rate or blood pressure. This makes it a critical therapy for patients with reduced exercise tolerance and ischemic symptoms.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Trizapime 80 Capsule offers a profitable B2B opportunity, serving hospitals, cardiology clinics, and specialty pharmacies across India with consistent demand and strong market potential.